Evidence map›Paper›PMID 31142361›Full record

ArticleCancer imaging : the official publication of the International Cancer Imaging Society2019

The role of

Te-Jui Hung, Luke McLean, Catherine Mitchell, Claire Pascoe, Nathan Lawrentschuk, Declan G Murphy, Amir Iravani, Dalveer Singh, Michael S Hofman, Lamiaa Zidan and 3 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Cancer imaging : the official publication of the International Cancer Imaging Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Two decades of FDG-PET/CT in seminoma: exploring its role in diagnosis, surveillance and follow-up.Cancer imaging : the official publication of the International Cancer Imaging Society · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Te-Jui HungCancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia. te-jui.hung@health.wa.gov.au.ORCID http://orcid.org/0000-0003-2396-2942
Luke McLeanDepartment of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.
Catherine MitchellDepartment of Pathology, Peter MacCallum Cancer Centre, Melbourne, Australia.
Claire PascoeDivision of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia.
Nathan LawrentschukDivision of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia.
Declan G MurphyDivision of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia.
Amir IravaniCancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia.
Dalveer SinghCancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia.
Michael S HofmanCancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia.
Lamiaa ZidanCancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia.
Tim AkhurstCancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia.
Jeremy LewinDepartment of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.
Rodney J HicksCancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia.
Peter MacCallum Cancer Centre · AUThe University of Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTesticular germ cell tumour is the commonest malignancy affecting males aged between 15 and 35, with an increased relative risk amongst those with a history of cryptorchidism. In patients presenting with locoregional metastatic disease, retroperitoneal and pelvic soft tissue masses are common findings on ultrasound and computed tomography, which has several differential diagnoses within this demographic cohort. On staging CASE PRESENTATIONS: In all three cases, the patients were males aged in their 30s and 40s who were brought to medical attention for back and lower abdominal pain of varying duration. Initial imaging evaluation with computed tomography and/or ultrasound revealed large abdominopelvic soft tissue masses, with lymphoproliferative disorders or soft tissue sarcomas being high on the list of differential diagnoses. As such, they were referred for staging FDG-PET/CT, all of whom demonstrated the pathognomonic constellation of, 1) unilateral absence of scrotal testicular activity, and 2) FDG-avid nodal masses along the typical testicular lymphatic drainage pathway. These characteristic patterns were corroborated by a targeted clinical history and examination which revealed a history of cryptorchidism, and elevated β-hCG in two of three patients. All were subsequently confirmed as metastatic seminoma on biopsy and open resection.

conclusionThese cases highlight the importance of clinical history and examination for the clinician, as well as a sound knowledge of the typical testicular lymphatic drainage pathway for the PET physician, which would assist with prompt recognition of the characteristic imaging patterns on FDG-PET/CT. It further anecdotally supports the utility of FDG-PET/CT in evaluating undiagnosed abdominopelvic masses, as well as a potential role in the initial staging of germ cell tumours in appropriately selected patients.

Indexed as

Positron Emission Tomography Computed TomographyAdultDiagnosis, DifferentialFluorodeoxyglucose F18HumansMaleNeoplasms, Germ Cell and EmbryonalRadiopharmaceuticalsRetroperitoneal NeoplasmsTesticular NeoplasmsFluorodeoxyglucose F18RadiopharmaceuticalsCryptorchidismFDG-PET/CTGerm cell tumourRetroperitonealSeminoma

Identifiers

PMID31142361
PMCPMC6542013
OpenAlexW2947216834

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.